Cardiol Therapeutics (CRDL) Q1 2026 Earnings
CRDL·Reported May 11, 2026·After market close
Diluted EPS came in at $-0.07 (+30.0% YoY).
Diluted EPS
$-0.07met estimate
Consensus: $-0.07
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about Cardiol Therapeutics's Q1 2026 earnings report.
Cardiol Therapeutics (CRDL) reported Q1 2026 earnings on May 11, 2026 after market close.
Cardiol Therapeutics reported diluted EPS of $-0.07 for Q1 2026.
EPS beat the consensus estimate of $-0.07 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 30.0% from $-0.10.